Bate Kenneth

Director at MDGL; Director at CUBIST PHARMACEUTICALS INC

Sold, on record
$29.5M
Dollars the filings state
Form 4 sales
10
Latest Nov 5, 2025
Form 144 notices
4
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice MDGLNotice
    Apr 1, 2024 2024

    Filed to sell 32,489 shares ($8.7M)

    Bate Kenneth, Director

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale MDGLRoutine
    Apr 2, 2024 +1 day

    Sold 32,489 shares at $252.86 ($8.2M)

    Bate Kenneth, Director

    10b5-1 planSold 96.4% of holdings ($8.5M position)1,198 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice MDGLNotice
    Feb 27, 2025 +331 days

    Filed to sell 20,000 shares ($7.1M)

    Bate Kenneth, Director

    No 10b5-1 planFiling

  4. 4 Form 4 sale MDGLUnusual
    Feb 27, 2025 same day

    Sold 20,000 shares at $356.44 ($7.1M)

    Bate Kenneth, Director

    No 10b5-1 planSold 91.3% of holdings ($7.8M position)1,912 shares leftFollows a Form 144Filing

  5. 5 Form 144 notice MDGLNotice
    Aug 15, 2025 +169 days

    Filed to sell 10,000 shares ($3.7M)

    Bate Kenneth, Director

    No 10b5-1 planFiling

  6. 6 Form 4 sale MDGLUnusual
    Aug 15, 2025 same day

    Sold 10,000 shares at $365.20 ($3.7M)

    Bate Kenneth, Director

    No 10b5-1 planSold 79.2% of holdings ($4.6M position)2,627 shares leftFollows a Form 144Filing

  7. 7 Form 144 notice MDGLNotice
    Nov 5, 2025 +82 days

    Filed to sell 16,575 shares ($8M)

    Bate Kenneth, Director

    No 10b5-1 plan0.8x usual sizeFiling

  8. 8 Form 4 sale MDGLUnusual
    Nov 5, 2025 same day

    Sold 16,575 shares at $484.31 ($8M)

    Bate Kenneth, Director

    No 10b5-1 planSold 86.3% of holdings ($9.3M position)2,627 shares left0.8x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Bate Kenneth
Source
Nov 5, 2025Nov 7, 2025MDGLDirectorForm 4 sale16,575$8M86.3%UnusualSEC
Nov 5, 2025Nov 5, 2025MDGLDirectorForm 144 notice16,575$8MNoticeSEC
Aug 15, 2025Aug 15, 2025MDGLDirectorForm 4 sale10,000$3.7M79.2%UnusualSEC
Aug 15, 2025Aug 15, 2025MDGLDirectorForm 144 notice10,000$3.7MNoticeSEC
Feb 27, 2025Feb 28, 2025MDGLDirectorForm 4 sale20,000$7.1M91.3%UnusualSEC
Feb 27, 2025Feb 27, 2025MDGLDirectorForm 144 notice20,000$7.1MNoticeSEC
Apr 2, 2024Apr 3, 2024MDGLDirectorForm 4 sale32,489$8.2M96.4%RoutineSEC
Apr 1, 2024Apr 1, 2024MDGLDirectorForm 144 notice32,489$8.7MNoticeSEC
Feb 3, 2014Feb 4, 2014CUBIST PHARMACEUTICALS INCDirectorForm 4 sale6,250$451k44.1%UnusualSEC
Jan 9, 2014Jan 9, 2014CUBIST PHARMACEUTICALS INCDirectorForm 4 sale10,000$700k55.8%UnusualSEC
Dec 2, 2013Dec 3, 2013CUBIST PHARMACEUTICALS INCDirectorForm 4 sale12,500$845k61.2%UnusualSEC
Jun 3, 2013Jun 3, 2013CUBIST PHARMACEUTICALS INCDirectorForm 4 sale2,500$137k30.0%UnusualSEC
May 15, 2013May 17, 2013CUBIST PHARMACEUTICALS INCDirectorForm 4 sale2,500$121k30.0%UnusualSEC
Mar 6, 2013Mar 7, 2013CUBIST PHARMACEUTICALS INCDirectorForm 4 sale5,000$238k46.1%UnusualSEC